The Effect of Continuous Glucose Monitoring On Glycemic Control In Gestational Diabetes Mellitus

The Effect of Continuous Glucose Monitoring On Glycemic Control In Gestational Diabetes Mellitus - The Effect of Continuous Glucose Monitoring In Gestational Diabetes Mellitus

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000028883

Enrollment

Registered

2017-09-01

Start date

2017-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational Diabetes Mellitus

Interventions

CGM will be performed for 14days on the day of first examination and in one month.

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: patients with gestational diabetes mellitus diagnosed by Japanise criteria of GDM in Bokutoh Hospital.

Exclusion criteria

Exclusion criteria: Concomitant disease or condition that may compromise patient

Design outcomes

Primary

Measure	Time frame
Glycemic control(Blood glucose, HbA1c) in perinatal period.	—

Secondary

Measure	Time frame
75gOGTT, data of CGM, data of SMBG, pregnancy outcomes.	—

Countries

Japan

Contacts

Public ContactAya Yoshihara

Tokyo Metropolitan Bokutoh Hospital Internal Medicine

aya.yoshihara@med.toho-u.ac.jp03-3633-6151

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026